South Korea
· Delayed Price · Currency is KRW PharmGen Science Statistics
Total Valuation
KRX:004720 has a market cap or net worth of KRW 77.27 billion. The enterprise value is 82.61 billion.
| Market Cap | 77.27B |
| Enterprise Value | 82.61B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:004720 has 18.16 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 18.16M |
| Shares Outstanding | 18.16M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -43.72% |
| Owned by Insiders (%) | 11.94% |
| Owned by Institutions (%) | 1.19% |
| Float | 15.12M |
Valuation Ratios
The trailing PE ratio is 656.21.
| PE Ratio | 656.21 |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.92, with an EV/FCF ratio of -42.59.
| EV / Earnings | 701.61 |
| EV / Sales | 0.48 |
| EV / EBITDA | 11.92 |
| EV / EBIT | 35.86 |
| EV / FCF | -42.59 |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.08 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 1.36 |
| Debt / FCF | -10.01 |
| Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is 0.05% and return on invested capital (ROIC) is 2.23%.
| Return on Equity (ROE) | 0.05% |
| Return on Assets (ROA) | 1.76% |
| Return on Invested Capital (ROIC) | 2.23% |
| Return on Capital Employed (ROCE) | 3.25% |
| Revenue Per Employee | 759.55M |
| Profits Per Employee | 521,017 |
| Employee Count | 226 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.28 |
Taxes
| Income Tax | -2.37B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.99% in the last 52 weeks. The beta is 0.66, so KRX:004720's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -16.99% |
| 50-Day Moving Average | 4,191.80 |
| 200-Day Moving Average | 4,423.75 |
| Relative Strength Index (RSI) | 46.19 |
| Average Volume (20 Days) | 96,819 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:004720 had revenue of KRW 171.66 billion and earned 117.75 million in profits. Earnings per share was 6.50.
| Revenue | 171.66B |
| Gross Profit | 108.36B |
| Operating Income | 9.66B |
| Pretax Income | -2.24B |
| Net Income | 117.75M |
| EBITDA | 14.29B |
| EBIT | 9.66B |
| Earnings Per Share (EPS) | 6.50 |
Balance Sheet
The company has 14.08 billion in cash and 19.42 billion in debt, giving a net cash position of -5.34 billion or -294.21 per share.
| Cash & Cash Equivalents | 14.08B |
| Total Debt | 19.42B |
| Net Cash | -5.34B |
| Net Cash Per Share | -294.21 |
| Equity (Book Value) | 248.65B |
| Book Value Per Share | 13,692.44 |
| Working Capital | 46.78B |
Cash Flow
In the last 12 months, operating cash flow was -1.29 billion and capital expenditures -652.90 million, giving a free cash flow of -1.94 billion.
| Operating Cash Flow | -1.29B |
| Capital Expenditures | -652.90M |
| Free Cash Flow | -1.94B |
| FCF Per Share | -106.82 |
Margins
Gross margin is 63.12%, with operating and profit margins of 5.63% and 0.07%.
| Gross Margin | 63.12% |
| Operating Margin | 5.63% |
| Pretax Margin | -1.30% |
| Profit Margin | 0.07% |
| EBITDA Margin | 8.32% |
| EBIT Margin | 5.63% |
| FCF Margin | n/a |
Dividends & Yields
KRX:004720 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | 0.15% |
| FCF Yield | -2.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 17, 2014. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 17, 2014 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
KRX:004720 has an Altman Z-Score of 1.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.9 |
| Piotroski F-Score | 4 |